Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bened Life is a biotechnology company specializing in the development and commercialization of psychobiotics, which are probiotic strains that support mental and neurological health via the gut-brain axis. The company's flagship product, Neuralli MP, utilizes the proprietary Lactobacillus plantarum PS128 strain, which has been clinically studied for its effects on conditions such as Autism Spectrum Disorder (ASD) and Parkinson's Disease. By modulating neurotransmitters like dopamine and serotonin, Bened Life's microbial therapies aim to provide non-pharmacological support for neurodivergent individuals and those with mental health challenges. The company operates as a science-first organization, bridging the gap between traditional supplements and medical-grade biotherapeutics through rigorous clinical research. Headquartered in the United States, Bened Life leverages the extensive R&D capabilities of its parent organization, Bened Biomedical Group, to advance the field of nutritional neurology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bened Life.